fujitsu-nus-to-develop-body-sensor-network-for-disease-management-and-prevention-oriented-healthcare-using-health-cloud

NUS, Fujitsu leverage use of 'cloud' in healthcare

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Fujitsu Laboratories, Europe; Fujitsu Asia and National University of Singapore (NUS), have inked a collaboration to establish a new joint research programme... Read more

ms-corissa-leung-singapore-senior-director-health-industry-accenture

Health tech to help chronic and aging patients

  • Singapore
  • |
  • Opinion
  • |
  • By Ms Corissa Leung
  • |
  • 0 Comment

The challenges of 21st century healthcare will soon exacerbate if two colliding forces are not addressed – rising chronic disease and aging populations. The World... Read more

4th-annual-biospectrum-cmr-survey-of-contract-and-clinical-research-organizations-cro-2012

CRO survey: India, China dominate market

  • Australia
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Contract and clinical research organizations (CROs) in the Asia Pacific (APAC) region are increasingly being leveraged by the biopharma industry to counter challenges... Read more

dr-ling-su-president-dia-board-of-directors-will-give-the-welcome-remarks-at-asia-regulatory-conference-on-jan-28

Singapore to host DIA Asia Regulatory Conference on Jan...

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: DIA will conduct the Asia Regulatory Conference 2013 at Raffles City Convention Center in Singapore during January 28-30, 2013. The meeting is being organized... Read more

telomerase-enzyme-causes-inflammation-and-progression-in-cancer

Study: Telomerase causes inflammation in cancer

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A*STAR scientists have identified the enzyme, telomerase, as a cause of chronic inflammation in human cancers. Chronic inflammation is now recognized... Read more

taurx-gets-usd31

Genting to acquire 20% equity stake in TauRx

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Singapore-based TauRx Pharmaceuticals has received equity investment of $31.5 million from Genting Management Singapore (GMS), a wholly owned subsidiary... Read more

Biotech-310x175_copy

Biofactory launches A*STAR technology-based ColoQuik kit...

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The Biofactory, a leading innovator in incubating biomedical and life sciences related technologies, introduced its ColoQuik line of label-free kits... Read more

dr-bruno-reversade-senior-principal-investigator-institute-of-medical-biology-astar-wins-european-molecular-biology-organization-embo-young-investigatorship-yip

A*Star man becomes first non-EU scientist to win EMBO YIP...

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Dr Bruno Reversade from A*STAR's Institute of Medical Biology (IMB) is the first scientist, based outside Europe, to have been awarded the prestigious... Read more

clearbridge-vitalsigns-is-leveraging-on-ecg-on-chip-technology

Clearbridge VitalSigns leverages on CardioLeaf

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Clearbridge VitalSigns, a Singapore-based medical device company, is leveraging its flagship product, CardioLeaf, into a family of three different products,... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X